SYNB-021225

N/A

Report date: 2025/07/09 15:12:27
NME

Base Information

Drug NameSYNB-021225
Drug Alias NameSYNB021225SYNB-021225
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSyneron Bio
China Registration ClassN/A

Develop Information

Active CompaniesSyneron Bio
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A